http://jcps.bjmu.edu.cn
The research group of Xinjing Tang developed efficient inhibition of SARS-CoV-2 using chimeric oligonucleotides through RNase L activation
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center
Journal of Chinese Pharmaceutical Sciences . 2021, (7): 621 -622 .